PDSB Insider Transactions

Transaction Date
(SEC Report)
Reporting Name Relationship Shrs. Owned Type Acq./Disp. Shrs. Transacted Price() Amount()
2024-01-22 Shepard Kirk V. officer: Chief Medical Officer 200,000 A-Award A 200,000 4.49 898,000.00
2024-01-22 Shepard Kirk V. 0 0 0.00 0.00
2023-12-04 Boesgaard Lars officer: Chief Financial Officer 200,000 A-Award A 200,000 5.28 1,056,000.00
2023-12-04 Boesgaard Lars 0 0 0.00 0.00
2023-07-14 Freitag Gregory Gene director 9,000 A-Award A 9,000 5.13 46,170.00
2023-07-14 BRAWLEY OTIS W director 9,000 A-Award A 9,000 5.13 46,170.00
2023-07-14 Ali-Jackson Kamil director 9,000 A-Award A 9,000 5.13 46,170.00
2023-07-14 SYKES RICHARD director 9,000 A-Award A 9,000 5.13 46,170.00
2023-07-14 Glover Stephen C. director 9,000 A-Award A 9,000 5.13 46,170.00
2023-07-14 Iliev Ilian director 9,000 A-Award A 9,000 5.13 46,170.00
2023-01-05 Brown Spencer D. director: Senior VP, General Counsel 20,400 A-Award A 20,400 0.00 0.00
2023-01-05 HILL MATTHEW C director: Chief Financial Officer 161,200 A-Award A 161,200 0.00 0.00
2023-01-05 CONN GREGORY director: Chief Scientific Officer 137,200 A-Award A 137,200 0.00 0.00
2023-01-05 BEDU-ADDO FRANK director: President/CEO 385,300 A-Award A 385,300 0.00 0.00
2023-01-05 WOOD LAUREN director: Chief Medical Officer 110,800 A-Award A 110,800 0.00 0.00
2022-12-02 BEDU-ADDO FRANK director: President/CEO 866,050 M-Exempt A 219,535 6.57 1,442,345.00
2022-12-02 BEDU-ADDO FRANK director: President/CEO 690,866 F-InKind D 175,184 9.78 1,713,300.00
2022-12-02 BEDU-ADDO FRANK director: President/CEO 0 M-Exempt D 219,535 0.00 0.00
2022-06-28 Glover Steve C director: 9,000 A-Award A 9,000 0.00 0.00
2022-06-28 Glover Steve C director 9,000 A-Award A 9,000 3.90 35,100.00
2022-06-28 Iliev Ilian director: 9,000 A-Award A 9,000 0.00 0.00
2022-06-28 Iliev Ilian director 9,000 A-Award A 9,000 3.90 35,100.00
2022-06-28 BRAWLEY OTIS W director: 9,000 A-Award A 9,000 0.00 0.00
2022-06-28 Freitag Gregory Gene director: 9,000 A-Award A 9,000 0.00 0.00
2022-06-28 Freitag Gregory Gene director 9,000 A-Award A 9,000 3.90 35,100.00
2022-06-28 SYKES RICHARD director: 9,000 A-Award A 9,000 0.00 0.00
2022-06-28 SYKES RICHARD director 9,000 A-Award A 9,000 3.90 35,100.00
2022-06-28 Ali-Jackson Kamil director: 9,000 A-Award A 9,000 0.00 0.00
2022-06-02 Brown Spencer D. director: Senior VP, General Counsel 150,000 A-Award A 150,000 0.00 0.00
2022-06-01 Brown Spencer D. 0 0 0.00 0.00
2022-01-19 CONN GREGORY 112,100 A-Award A 112,100 6.28 703,988.00
2022-01-19 BEDU-ADDO FRANK 291,500 A-Award D 291,500 6.28 1,830,620.00
2022-01-19 WOOD LAUREN director: Chief Medical Officer 88,600 A-Award A 88,600 6.28 556,408.00
2022-01-19 WOOD LAUREN officer: Chief Medical Officer 88,600 A-Award A 88,600 6.28 556,408.00
2021-12-13 HILL MATTHEW C 4,075 P-Purchase A 100 9.00 900.00
2021-12-13 HILL MATTHEW C 3,975 P-Purchase A 100 9.00 900.00
2021-12-13 HILL MATTHEW C 3,875 P-Purchase A 400 8.90 3,560.00
2021-12-13 HILL MATTHEW C 3,475 P-Purchase A 2,500 9.00 22,500.00
2021-10-19 HILL MATTHEW C 202,800 A-Award A 202,800 12.03 2,439,684.00
2021-10-18 HILL MATTHEW C 975 D 0 0.00 0.00
2021-09-30 Trochimiuk Janetta 0 D 10,000 2.88 28,800.00
2021-09-30 Trochimiuk Janetta 0 D 5,000 1.45 7,250.00
2021-09-30 Trochimiuk Janetta 0 D 27,750 2.43 67,432.00
2021-06-16 Bloomquist DeLyle W 193,888 P-Purchase A 10,000 9.88 98,778.00
2021-06-16 Bloomquist DeLyle W 183,888 M-Exempt A 2,970 5.99 17,790.00
2021-06-16 Bloomquist DeLyle W 6,030 M-Exempt D 2,970 5.99 17,790.00
2021-06-15 BEDU-ADDO FRANK 673,681 M-Exempt A 53,174 6.57 349,353.00
2021-06-15 BEDU-ADDO FRANK 646,515 F-InKind D 27,166 12.86 349,355.00
2021-06-15 BEDU-ADDO FRANK 0 M-Exempt D 53,174 6.57 349,353.00
2021-06-17 BRAWLEY OTIS W 9,000 A-Award A 9,000 9.95 89,550.00
2021-06-15 Glover Steve C 63,790 P-Purchase A 5,882 8.50 49,997.00
2021-06-17 Glover Steve C 9,000 A-Award A 9,000 9.95 89,550.00
2021-06-15 Ali-Jackson Kamil 11,764 P-Purchase A 11,764 8.50 99,994.00
2021-06-17 Ali-Jackson Kamil 9,000 A-Award A 9,000 9.95 89,550.00
2021-06-17 SYKES RICHARD 9,000 A-Award A 9,000 9.95 89,550.00
2021-06-17 Iliev Ilian 9,000 A-Award A 9,000 9.95 89,550.00
2021-06-15 VAN VOORHEES SETH 17,647 P-Purchase A 17,647 8.50 150,000.00
2021-06-15 Freitag Gregory Gene 46,153 P-Purchase A 5,882 8.50 49,997.00
2021-06-17 Freitag Gregory Gene 9,000 A-Award A 9,000 9.95 89,550.00
2021-01-04 VAN VOORHEES SETH 202,800 A-Award A 202,800 2.28 462,384.00
2021-01-01 VAN VOORHEES SETH 0 0 0.00 0.00
2020-12-08 CONN GREGORY 122,400 A-Award A 122,400 2.43 297,432.00
2020-12-08 WOOD LAUREN 210,500 A-Award A 210,500 2.43 511,515.00
2020-12-08 King Michael N. 50,000 A-Award A 50,000 2.43 121,500.00
2020-12-08 BEDU-ADDO FRANK 707,800 A-Award A 707,800 2.43 1,719,954.00
2020-11-03 BRAWLEY OTIS W 9,000 A-Award A 9,000 2.09 18,810.00
2020-11-03 BRAWLEY OTIS W 0 0 0.00 0.00
2019-03-15 King Michael N. director: Interim Chief Financial Office 0 D 52,934 6.87 363,657.00
2019-03-14 King Michael N. director: Interim Chief Financial Office 0 D 44,871 9.04 405,634.00
2020-06-23 Glover Steve C 9,000 A-Award A 9,000 1.45 13,050.00
2020-06-23 Freitag Gregory Gene 9,000 A-Award A 9,000 1.45 13,050.00
2020-06-23 SYKES RICHARD 9,000 A-Award A 9,000 1.45 13,050.00
2020-06-23 Ali-Jackson Kamil 3,033 A-Award A 3,033 1.45 4,398.00
2020-06-23 WOOD LAUREN 35,000 A-Award A 35,000 1.45 50,750.00
2020-06-23 Bloomquist DeLyle W 9,000 A-Award A 9,000 1.45 13,050.00
2020-06-23 Iliev Ilian 1,874 A-Award A 1,874 1.45 2,717.00
2020-06-23 CONN GREGORY director: Chief Scientific Officer 35,000 A-Award A 35,000 1.45 50,750.00
2020-06-23 CONN GREGORY officer: Chief Scientific Officer 35,000 A-Award A 35,000 1.45 50,750.00
2020-06-23 BEDU-ADDO FRANK 125,000 A-Award A 125,000 1.45 181,250.00
2020-04-08 Iliev Ilian 4,500 A-Award A 4,500 0.72 3,240.00
2020-04-08 Iliev Ilian 0 0 0.00 0.00
2020-03-23 Trochimiuk Janetta 0 D 10,000 2.88 28,800.00
2020-02-21 Ali-Jackson Kamil 9,000 A-Award A 9,000 1.31 11,790.00
2020-02-21 Ali-Jackson Kamil 0 0 0.00 0.00
2020-02-14 Freitag Gregory Gene 40,271 A-Award A 38,400 1.30 49,920.00
2020-02-14 SYKES RICHARD 445,108 A-Award A 384,615 1.30 500,000.00
2020-02-14 Saik Andrew 42,549 A-Award A 38,400 1.30 49,920.00
2020-02-14 Glover Steve C 57,908 A-Award A 38,400 1.30 49,920.00
2019-06-28 Glover Steve C director 9,000 A-Award A 9,000 5.99 53,910.00
2019-06-28 Glover Steve C director 9,000 A-Award A 9,000 5.99 53,910.00
2019-06-28 SYKES RICHARD director 9,000 A-Award A 9,000 5.99 53,910.00
2019-06-28 LOUGHLIN JAMES J director 9,000 A-Award A 9,000 5.99 53,910.00
2019-06-28 Freitag Gregory Gene director 9,000 A-Award A 9,000 5.99 53,910.00
2019-06-28 BEDU-ADDO FRANK director, 10 percent owner, officer: President/CEO 100,000 A-Award A 100,000 5.99 599,000.00
2019-06-28 Bloomquist DeLyle W director, 10 percent owner: 9,000 A-Award A 9,000 5.99 53,910.00
2019-06-06 WOOD LAUREN officer: Chief Medical Officer 62,715 A-Award A 62,715 6.39 400,749.00
2019-06-06 CONN GREGORY officer: Chief Scientific Officer 40,000 A-Award A 40,000 6.39 255,600.00
2019-06-06 Saik Andrew director, officer: Chief Financial Officer 62,715 A-Award A 62,715 6.39 400,749.00
2019-04-02 Glover Steve C 0 0 0.00 0.00
2019-03-15 Bloomquist DeLyle W 605,023 I 0 0.00 0.00

Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.